Tonix Pharmaceuticals Holding Corp (TNXP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $58.49M
Last updated: Nov 17, 2026 at 4:28 PM ET
Tonix Pharmaceuticals Holding Corp (TNXP) Stock Chart
Tonix Pharmaceuticals Holding (TNXP) has a latest price of $2.94 on Nov 17, 2026, 85.7% below its 52-week high of $20.56. Its price fell 81.5% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 83.2%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $346,066,526.96 in Jan 2017 and its lowest $5.10 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart TNXP with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TNXP.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 76.9%, and over 6 months it fell 78.6%. The month-end price fell 99.7% over the 3 years through Oct 2026, a compound annual decline of 86.1%.
| Period | Change |
|---|---|
| 1 month | -48.7% |
| 3 months | -76.9% |
| 6 months | -78.6% |
| 12 months | -81.5% |
| 12 months, with dividends | -81.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -99.7% | -86.1% |
| 5 years | -100.0% | -89.2% |
| 10 years | -100.0% | -83.2% |
Price by Year
Its best calendar year was 2017, when the price fell 26.6%, and its weakest was 2024, when it fell 97.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $5.10 | -67.3% |
| 2025 | $15.62 | -52.6% |
| 2024 | $32.98 | -97.4% |
| 2023 | $1,291.67 | -83.5% |
| 2022 | $7,808.49 | -96.6% |
| 2021 | $229,662.33 | -47.0% |
| 2020 | $433,385.72 | -42.3% |
| 2019 | $751,201.92 | -94.7% |
| 2018 | $14,125,164.37 | -93.6% |
| 2017 | $221,508,259.37 | -26.6% |
Trading Range
The price is 59.8% below its 50-day average of $7.31 and 74.8% below its 200-day average of $11.65.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $2.94 | |
| 52-week high | $20.56 | -85.7% |
| 52-week low | $2.81 | +4.6% |
| 50-day average | $7.31 | -59.8% |
| 200-day average | $11.65 | -74.8% |
Price Risk
Over 3 years, its largest fall from a peak was 99.9%.
| Measure | Value |
|---|---|
| 1-year beta | 1.65 |
| Largest fall, 1 year | -85.5% |
| Largest fall, 3 years | -99.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About TNXP
What is TNXP's 1-year price change?
Tonix Pharmaceuticals Holding's price fell 81.5% over the past 12 months. With dividends included, the 12-month total return was -81.5%.
What is TNXP's 5-year price change?
Tonix Pharmaceuticals Holding's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 89.2%. These figures leave out dividends.
What is TNXP's 52-week high and low?
Tonix Pharmaceuticals Holding's 52-week high is $20.56 and its 52-week low is $2.81. Its latest price of $2.94 on Nov 17, 2026 is 85.7% below the high.
What is TNXP's beta?
Tonix Pharmaceuticals Holding's 1-year beta against the S&P 500 is 1.65, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 85.5%.
Is the TNXP chart free?
Yes. Advanced Charting for TNXP is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
TNXP pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors